A detailed history of Sei Investments CO transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Sei Investments CO holds 23,378 shares of AGIO stock, worth $948,211. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,378
Holding current value
$948,211
% of portfolio
0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$27.55 - $48.83 $644,063 - $1.14 Million
23,378 New
23,378 $1.01 Million
Q3 2023

Nov 14, 2023

SELL
$24.36 - $28.18 $10,913 - $12,624
-448 Reduced 4.39%
9,752 $241,000
Q2 2023

Aug 11, 2023

SELL
$21.38 - $29.19 $32,882 - $44,894
-1,538 Reduced 13.1%
10,200 $288,000
Q1 2023

May 12, 2023

BUY
$21.74 - $30.93 $255,184 - $363,056
11,738 New
11,738 $269,000
Q3 2022

Nov 14, 2022

BUY
$19.51 - $34.14 $22,065 - $38,612
1,131 Added 11.64%
10,847 $307,000
Q2 2022

Aug 15, 2022

BUY
$17.06 - $31.42 $165,754 - $305,276
9,716 New
9,716 $213,000
Q4 2021

Feb 14, 2022

SELL
$29.58 - $49.78 $184,934 - $311,224
-6,252 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$41.92 - $58.18 $735,947 - $1.02 Million
-17,556 Reduced 73.74%
6,252 $253,000
Q2 2021

Aug 06, 2021

SELL
$52.06 - $61.27 $55,548 - $65,375
-1,067 Reduced 4.29%
23,808 $1.28 Million
Q1 2021

May 12, 2021

SELL
$44.23 - $57.5 $7,297 - $9,487
-165 Reduced 0.66%
24,875 $1.09 Million
Q4 2020

Feb 08, 2021

SELL
$33.21 - $46.54 $206,267 - $289,059
-6,211 Reduced 19.87%
25,040 $1.04 Million
Q3 2020

Dec 04, 2020

SELL
$33.87 - $55.93 $371,757 - $613,887
-10,976 Reduced 25.99%
31,251 $1.07 Million
Q3 2020

Nov 06, 2020

SELL
$33.87 - $55.93 $124,810 - $206,102
-3,685 Reduced 8.03%
42,227 $1.45 Million
Q2 2020

Aug 17, 2020

BUY
$34.45 - $53.48 $311,979 - $484,314
9,056 Added 24.57%
45,912 $2.45 Million
Q2 2020

Aug 11, 2020

BUY
$34.45 - $53.48 $968,320 - $1.5 Million
28,108 Added 321.31%
36,856 $1.93 Million
Q1 2020

May 14, 2020

BUY
$31.52 - $53.81 $4,381 - $7,479
139 Added 1.61%
8,748 $284,000
Q4 2019

Feb 06, 2020

SELL
$30.08 - $50.59 $20,304 - $34,148
-675 Reduced 7.27%
8,609 $385,000
Q3 2019

Nov 12, 2019

BUY
$32.4 - $49.58 $16,167 - $24,740
499 Added 5.68%
9,284 $269,000
Q2 2019

Aug 14, 2019

SELL
$46.17 - $68.1 $2,216 - $3,268
-48 Reduced 0.54%
8,785 $412,000
Q1 2019

May 15, 2019

SELL
$45.92 - $67.67 $120,402 - $177,430
-2,622 Reduced 22.89%
8,833 $585,000
Q4 2018

Feb 13, 2019

BUY
$42.73 - $76.53 $30,936 - $55,407
724 Added 6.75%
11,455 $837,000
Q3 2018

Nov 08, 2018

BUY
$71.67 - $91.95 $116,965 - $150,062
1,632 Added 17.94%
10,731 $825,000
Q2 2018

Aug 03, 2018

BUY
$73.22 - $99.55 $478,858 - $651,057
6,540 Added 255.57%
9,099 $767,000
Q1 2018

May 11, 2018

SELL
$59.83 - $86.53 $18,547 - $26,824
-310 Reduced 10.81%
2,559 $210,000
Q4 2017

Feb 08, 2018

BUY
$52.12 - $72.33 $145,154 - $201,439
2,785 Added 3315.48%
2,869 $164,000
Q3 2017

Nov 06, 2017

BUY
$54.89 - $67.12 $4,610 - $5,638
84
84 $5,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.22B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.